This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
This poses a significant challenge for pharmaceuticalmanufacturers, not least because of the technical challenges related to operations, supply chain and the environment. This article explores the potential impact of the proposal and considers how manufacturers can ensure the safety and reliability of their products.
The paper is intended to initiate communication with stakeholders, including industry and academia, to foster mutual learning and discussion. Advanced manufacturing “Advanced analytics leveraging AI/ML in the pharmaceuticalmanufacturing industry offers… possibilities [such as]… enhancing process control… and preventing batch losses.”
Estimating the appearance of large particles from the continuous monitoring is important for process control, according to the research published in Nature Communications. This limits its application to surfaces encountered in pharmaceuticalsmanufacturing. Millennium Pharmaceuticals, Inc., Zhang et al.
Revolutionize pharmaceuticalmanufacturing through paperless manufacturing. Even the simplest “paper on glass” digital systems enable streamlined workflows and can ensure real-time data access and seamless communication. Paperless facilities are a reality! Transform your operations today!
We may still continue to send you service-related and other non-promotional communications. By Cytiva Thematic You have a right to withdraw your consent at any time, by clicking here. For more information relating to our privacy practices, we invite you to review our privacy policy. Sign up for our daily news round-up!
Subscribe Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Give your business an edge with our leading industry insights.
The overarching principle set out in Codes of Practice, and in particular the Principles for the use of digital channels in the EFPIA Code , is that the legislation and Codes of Practice apply equally to communications by companies on social media and digital channels.
APL is a growing India multinational pharmaceuticalmanufacturing firm with turnover of over US$2.8 Chemistry/ B.Tech Chemical/ B.Pharm) with good communication skills are highly preferred. Aurobindo Pharma-Openings for Freshers – Project Management -Apply Now. Company Profile: Aurobindo Pharma Ltd’ (APL).
Clear Communication is Key Establish clear channels of communication from the outset. Managing Quality and Compliance Quality and regulatory compliance are non-negotiable in pharmaceuticalmanufacturing. Ensuring Data Integrity Data integrity is paramount in pharmaceuticalmanufacturing.
Subscribe Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Give your business an edge with our leading industry insights.
But the new Joint Guidance on Virtual and Hybrid International Medical Congresses, from the International Federation of PharmaceuticalManufacturers and Associations (IFPMA), the European Federation of Pharmaceutical Industries and Associations (EFPIA), and the Pharmaceutical Research and Manufacturers of America (PhRMA) is here to plug that gap.
Subscribe Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Give your business an edge with our leading industry insights.
Eli Lilly and Ivy Tech Community College, Indiana, US, have announced a new scholarship programme, known as Lilly Scholars @ Ivy Tech, which aims to support first generation students, and students who faced socioeconomic barriers, in pursuing credentials in quality, pharmaceuticalmanufacturing or similar industries.
ServBlock, an Irish start-up, and Irish Manufacturing Research (IMR), have been given EU funding to build a data exchange system for outsourced pharmaceuticalmanufacturing. ServBlock is a company which uses blockchain-based auditing and compliance to help pharma manufacturers guarantee quality across their supply chain.
Subscribe Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Give your business an edge with our leading industry insights.
Subscribe Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Give your business an edge with our leading industry insights.
Subscribe Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Give your business an edge with our leading industry insights.
Subscribe Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Give your business an edge with our leading industry insights.
The time is ripe for pharmaceuticalmanufacturers to evaluate and evolve how they engage with patients, determining how and when to best incorporate patient perspectives during product development and to discover how to use patient insights more effectively to articulate the value of their product within the HTA process.
Subscribe Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Give your business an edge with our leading industry insights.
Bob is a life sciences and technology marketing leader with more than 25 years of experience working directly for pharmaceuticalmanufacturers (Merck, AstraZeneca, and Shire) and for technology companies that serve the industry (Appature, IQVIA, and Sparta). Bob is currently Sr.
Subscribe Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Give your business an edge with our leading industry insights.
Subscribe Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Give your business an edge with our leading industry insights.
Indeed, a key aspect of EU GMP Annex 1 is the requirement for pharmaceuticalmanufacturers to develop a comprehensive Contamination Control Strategy (CCS) that documents their approach to assuring the sterile drug product’s high quality and, therefore, enhancing patient safety.
Given the strict state and federal regulations governing how manufacturerscommunicate with or support patients, companies face significant legal and regulatory risk when managing PAP programs.
He mentions that OPPI member companies follow the stringent OPPI Code of Pharmaceutical Practices 2019 (OPPI Code) which is based on the International Federation of PharmaceuticalManufacturers and Associations (IFPMA) Code.
Subscribe Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Give your business an edge with our leading industry insights.
Her expertise includes preparation and maintenance of licensing documentation, communications with state boards and government agencies, conducting research, and the preparation of associated licensing documentation and applications.
Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address. The parallel shift to using real-world data (RWD) provides the ideal framework for further investigation into SDoH. Sign up for our daily news round-up!
The panel also highlights adaptive challenges in leadership, such as addressing generational changes, language and communication barriers, and the evolving needs of people within the healthcare and pharmaceutical industry. Telemedicine is gaining prominence, providing patients with enhanced care and effective condition management.
billion in 340B savings is at risk, due to increasing limitations imposed by pharmaceuticalmanufacturers which could further strain the healthcare safety net and patient care services. Engage in proactive communications with 340B program stakeholders Foster transparent relationships with drug manufacturers and wholesalers.
As these innovations – which have the potential to be transformative for patients – enter uncharted regulatory territory, the pathway is not always clear or well-defined, which is why Astellas adopts a proactive approach to early communication with health authorities. “We
340B ESP has added a shameless layer of headaches to 340B programs According to its website , “340B ESP allows 340B covered entities and pharmaceuticalmanufacturers to work collaboratively to resolve duplicate discounts.” There are many places where communication failures can and do occur.
Advanced manufacturing technologies The legislation also calls for HHS to support development and implementation of advanced and continuous pharmaceuticalmanufacturing technologies through creation of national centers of excellence.
His article on Omnichannel approaches was published in Pharmaceutical Executive and European PharmaceuticalManufacturer. Viseven team keeps pushing the boundaries of the tech industry for pharma, coming up with new and more sophisticated ways to build communication in the MarTech area. And remember Pavel Klymenko?
To build an advanced pharmaceuticalmanufacturing cluster in the Richmond-Petersburg area, the Alliance for Building Better Medicine aims to support the early growth of local pharmaceuticalmanufacturers. The US Department of Commerce’s Economic Development Administration (EDA) awarded the organization $52.9
The communications I have seen and heard from the big 3 to small dispensers are irresponsible and seem like attempts to sabotage compliance, in my view.
While focuses on evaluating and establishing supplier reliability for pharmaceuticalmanufacturing companies and compounding pharmacies, its high-level elements of supplier qualification can also be applied to suppliers of foods and dietary supplement ingredients. Senior Director, General Chapters Global Science and Standards Division.
Table of Contents Quality risk management principles are already effectively utilized in many areas of pharmaceuticalsmanufacturing business. The purpose of the output from the risk management process is: – To share and communicate information about the risks and how they are controlled. Checkout sample preview s.
Effectively managing internal politics does not mean you have to be subdued; you must communicate in an effective way that retains your values. DS: By constantly improving the design of our isolators, we are making pharmaceuticalmanufacturing more sustainable here at Envair Technology. This is hugely exciting for me.
Suresh Kannan: This latest semi-annual platform update brings innovative revenue optimization and compliance solutions to our high-tech and life sciences customers, including pharmaceuticalmanufacturers. Specifically, our Fall 2022 release helps our pharma customers achieve compliance and meet their strategic objectives quickly.
Tablet manufacturing, which is the most common OSD form, takes an API dry powder ingredient and compresses it to form tablets, which can be coated or uncoated. Compared to other dosage forms, tablets are simpler to manufacture, package, and transport. Please check your email to download the Webinar.
Container Closure Integrity Testing (CCIT) is used to evaluate the ability of a pharmaceutical’s primary packaging to protect the sterility of its contents. On a regular basis, pharmaceuticalmanufacturers are performing CCIT during commercial production to ensure that packaging processes are operating as they should.
By ensuring that any inherent limitations or biases are recognized, addressed, and clearly communicated to clinicians and patients, the FDA can help sustain public trust in AI-driven regulatory processes. These variables, tailored to the intended users, can help identify where improvements are needed to support confident decision-making.
We organize all of the trending information in your field so you don't have to. Join 11,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content